Search Results for 'benign prostatic hyperplasia'
-
Surgical
Olympus' Non-Surgical BPH Device Wins FDA De Novo
The iTind flexible three-strut nitinol device can be placed during an in-office procedure.Olympus 04.06.20
-
Former Visiogen Chief Executive Tapped to Lead PROCEPT BioRobotics
New CEO also held the top position at Avedro, which was acquired by Glaukos in November 2019.Business Wire 03.19.20
-
Diagnostics
Progress in Noninvasive Urine Test for Prostate Cancer
Liquid biopsy test will detect prostate cancer from RNA and other metabolic chemicals in the urine.John Hopkins Medicine 03.02.20
-
Teleflex's UroLift Wins FDA Nod to Treat Larger Prostates
UroLift can now be used to treat benign prostatic hyperplasia in prostates between 80cc and 100cc.GlobeNewswire 01.07.20
-
FDA Approves Clinical Trial of a New Treatment Approach for Enlarged Prostate
Study will be conducted at 20 medical facilities throughout the United States.Urotronic Inc. 11.05.19
-
Financial Executive Joins Profound Medical’s Board
New appointment increases board membership to seven.Globe Newswire 10.07.19
-
Profound Medical Sells First TULSA-PRO System in Japan
Japan has the highest number of MRI units per person of all OECD countries.Globe Newswire 08.29.19
-
-
Cardiovascular
Embolx Extends the Sniper Balloon Occlusion Microcatheter Family With Launch of New K-Tip Design
New shaped tip design improves access into torturous vessels.Business Wire 06.27.19
-
PROCEPT BioRobotics Appoints Chief Financial Officer
New hire most recently served as senior vice president and chief financial officer of Accuray Inc.Business Wire 12.19.18
-
Diagnostics | Surgical
Past Dues: Medtech's 2018 Year in Review
The industry confronted old ghosts in 2018 as it defended itself against a documentary and crammed for regulatory changes.Michael Barbella, Managing Editor 11.26.18
-
Embolx Earns CE Mark Certification for Sniper Balloon Occlusion Microcatheters
Product is designed for pressure-directed treatment of tumors, enlarged prostate, and fibroids.Business Wire 10.05.18
-
Surgical
Boston Scientific to Acquire Augmenix for Up to $600 Million
Acquisition expands portfolio of men's health in-office procedures with adjunctive therapy for prostate cancer patients.Boston Scientific 09.07.18
-
Surgical
OmniGuide to Acquire Surgical Laser Products Maker Lisa Laser
OmniGuide adds laser hardware units, laser fibers, endoscopes, and laser assisted surgery accessories to its portfolio.Business Wire 08.07.18
-
Urotronic’s Drug-Coated Balloon Catheter Granted License for Urethral Stricture Treatments in Canada
Optilume combines balloon dilation with the delivery of an anti-proliferative drug to prevent blockage recurrence.Urotronic 08.02.18
-
-
Embolx Signs Agreement With U.S. Government for Sniper Balloon Occlusion Microcatheter
Product alters blood flow‐dynamics by controlling pressure to increase therapeutic agent delivery into target areas.Business Wire 07.05.18
-
PROCEPT BioRobotics’ Aquablation Meets Primary Endpoints in WATER II Study
Procedure confirmed as a safe, effective, heat-free treatment of BPH in a broad range of prostates.Business Wire 07.02.18
-
Cardiovascular | Surgical
FDA OKs Embolx's Balloon Occlusion Microcatheter for Pressure-Directed Arterial Embolization Therapy
Comes in multiple lengths, enabling radial arterial access; improves navigation therapy through complex vascular structures.Business Wire 06.28.18
-
FDA Approves Second U.S. Study of Therapy Aimed at Better Treating Urethral Strictures
Urotronic’s Optilume Drug Coated Balloon catheter offers promise of simple in-office procedure.Urotronic Inc. 05.18.18
-
Surgical
Boston Scientific Closes NxThera Acquisition
NxThera's Rezūm system complements the company's existing portfolio of treatment options for symptomatic BPH.Boston Scientific 04.30.18
-
Surgical
Boston Scientific Buys NxThera for Up to $406M
Boston Scientific will gain the Rezūm system, a minimally invasive therapy for benign prostatic hyperplasia.Boston Scientific 03.21.18
-
PROCEPT BioRobotics Completes Enrollment in WATER II Pivotal Clinical Trial
Study evaluates heat-free, robotic Aquablation therapy in large prostates for patients with lower urinary tract symptoms.Business Wire 01.26.18
-
Surgical
PROCEPT BioRobotics Announces First Commercial Aquablation Cases Completed in Germany
Company also initiates FRANCAIS WATER clinical trial.Business Wire 11.14.17
-
Industry Caps Third Quarter with Flurry of M&A Deals
...Mark Bonifacio, Founder and President, Bonifacio Consulting Services 10.05.17
-
Surgical
Teleflex to Acquire NeoTract for $1.1B
Significantly advances Teleflex’s offering of urological solutions.Business Wire 09.05.17
-
Merit Medical’s Embosphere Microspheres Receive FDA De Novo Classification
The indication now includes prostatic artery embolization (PAE) for symptomatic benign prostatic hyperplasia.Merit Medical Systems Inc. 07.17.17
-
NeoTract Inc. Announces Positive Five-Year Results for Minimally Invasive UroLift System
Highlights from pivotal L.I.F.T. randomized study presented in the United States.Business Wire 05.30.17
-
Data Affirms Ability of Spanner Temporary Prostate Stent to Replace Urinary Catheters
Information showed The Spanner allowed patients to maintain natural urination.Business Wire 05.24.17
-
Medifocus Inc. Announces Appointment of New CEO
William Jow, M.D. will replace Augustine Y. Cheung, Ph.D., the founder of the company.PR Newswire 10.11.16
-
Cardiovascular | Contract Manufacturing | Software & IT
-
SRS Medical Receives CE Mark Approval for Spanner Prostate Stent
Product is an alternative to indwelling (Foley), intermittent urinary catheters for BOO patients.Business Wire 07.01.16
-
Data Shows Excellent Durability of NeoTract's UroLift System at Four Years
Studies demonstrate sustained symptom relief and improved quality of life.Business Wire 05.19.16
-
Data Show Excellent Durability of Results for NeoTract Inc.'s UroLift System
Studies evaluating treatment for enlarged prostate demonstrate sustained symptom relief, improved quality of life.Business Wire 05.11.16
-
New Data on Minimally Invasive Prostate Treatment Technology from NeoTract
Data show favorable results for UroLift implant compared to standard TURP procedure.Videos
